MarketsStocksSUNPHARMA
SU

Sun Pharmaceutical

NSE: SUNPHARMABSE: 524715Healthcare
Download Research Report7-page PDF
1,791.70
+0.53%
NSE · auto-updates while market open
Prev Close
₹1,679.20
Day High
₹1,803.50
Day Low
₹1,773.50
Mkt Cap
₹4.32 L Cr
P / E
37.5
P / B
5.2
ROE
14.8%
52W High
₹1,916.60
52W Low
₹1,548.00
Key Metrics
Market Cap
₹4.32 L Cr
P / E
37.52
P / B
5.17
EV / EBITDA
25.58
ROCE
19.1%
ROE
14.8%
Debt / Equity
0.05
Book Value
₹348.31
EPS
₹47.80
Div Yield
1.2%
Face Value
₹1
Promoter Holding
54.5%
Revenue · ₹ Cr
33k
FY20
33k
FY21
39k
FY22
44k
FY23
48k
FY24
53k
FY25
58k
FY26
Net Profit · ₹ Cr
4.2k
FY20
2.3k
FY21
3.4k
FY22
8.5k
FY23
9.6k
FY24
11k
FY25
12k
FY26
EPS · ₹ per share
₹15.7
FY20
₹12.1
FY21
₹13.6
FY22
₹35.3
FY23
₹39.9
FY24
₹45.6
FY25
₹47.8
FY26
P / E Ratio · price ÷ TTM EPS
2239567454250-4Jun 21Feb 23Oct 24Jun 26
P/E 37.4×Median 37.9×TTM EPS
Q1 2026 snapshot
Sales
₹15.07K Cr
Operating profit
-
OPM
-
Net profit
₹2.71K Cr
EPS
₹11.30
Scorecard · 7 axes
Quality
Strong
86/100
Valuation
Avg
37.5×
Growth
Strong
+23.3%
Profitability
Good
16.9%
Performance
Weak
+5.9%
Entry Point
Weak
93%
Red Flags
Strong
0 flags
Shareholding Pattern
54.5%Promoter
Promoter54.5%
FII15.9%
DII21.1%
Public8.5%
Quarterly Results · ₹ Cr
QuarterFY24 12QFY25 03QFY25 06QFY25 09QFY25 12QFY26 03Q
Revenue13,675.4613,571.7114,315.8614,948.2316,099.3815,070.29
Net Profit2,912.982,153.932,292.873,124.953,381.172,709.66
NPM %21.3%15.9%16.0%20.9%21.0%18.0%
AlertPre-trade